BF Biosciences Limited (PSX:BFBIO)

Market Cap	14.67B
Revenue (ttm)	4.08B
Net Income (ttm)	399.91M
Shares Out	88.33M
EPS (ttm)	6.32
PE Ratio	26.30
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,064,275
Average Volume	1,888,762
Open	156.57
Previous Close	166.52
Day's Range	155.11 - 173.00
52-Week Range	76.06 - 253.97
Beta	n/a
RSI	28.55
Earnings Date	Apr 25, 2025

About BF Biosciences

BF Biosciences Limited, a diversified biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products. It offers a range of products in the areas of nephrology, cardiology, gastroenterology, diabetes, oncology, anti-viral, and hepatology. The company was incorporated in 2006 and is headquartered in Raiwind, Pakistan. BF Biosciences Limited is a subsidiary of Ferozsons Laboratories Limited.

• Industry: Pharmaceutical Preparations
• Founded: 2006
• Country: Pakistan
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: BFBIO

Financial Performance

In 2024, BF Biosciences's revenue was 3.66 billion, an increase of 102.19% compared to the previous year's 1.81 billion. Earnings were 385.41 million, an increase of 158.57%.